Skip to main content
Stanley Cohan, MD, Neurology, Portland, OR, Providence St. Vincent Medical Center

StanleyLCohanMD

Neurology • Portland, OR

Physician

Join to view full profile

Dr. Cohan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cohan's full profile

Already have an account?

Education & Training

  • MedStar Health/Georgetown University Hospital
    MedStar Health/Georgetown University HospitalResidency, Neurology, 1973 - 1974
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1969 - 1971
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1968 - 1969
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1968

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1999 - 2025
  • DC State Medical License
    DC State Medical License 1971 - 2000
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Quality of Life Among Injectable and Oral Disease-Modifying Therapy Users in the Pacific Northwest Multiple Sclerosis Registry
    Quality of Life Among Injectable and Oral Disease-Modifying Therapy Users in the Pacific Northwest Multiple Sclerosis RegistryDecember 4th, 2020
  • I Have MS and I’m Very Lucky
    I Have MS and I’m Very LuckyMay 22nd, 2018
  • New OCREVUS (Ocrelizumab) Data at AAN Demonstrate Significant Reductions in Disease Activity and Disability Progression in Relapsing Multiple Sclerosis
    New OCREVUS (Ocrelizumab) Data at AAN Demonstrate Significant Reductions in Disease Activity and Disability Progression in Relapsing Multiple SclerosisApril 23rd, 2018
  • Join now to see all

Hospital Affiliations

Dr. Stanley Cohan, Dr. Stanley Cohan, MD, Dr. S Cohan, Dr. Stanley L Cohan